CPIG
GILD icon

Chicago Partners Investment Group’s Gilead Sciences GILD Stock Holding History

Chicago Partners Investment Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Buy
10,079
+2,357
+31% +$311K 0.03% 527
2026
Q1 		$1.03M Buy
7,722
+590
+8% +$82.6K 0.02% 541
2025
Q4 		$969K Sell
7,132
-208
-3% -$25.3K 0.02% 484
2025
Q3 		$865K Buy
7,340
+523
+8% +$59.4K 0.02% 469
2025
Q2 		$774K Buy
6,817
+48
+0.7% +$5.11K 0.02% 459
2025
Q1 		$669K Sell
6,769
-360
-5% -$37.1K 0.02% 442
2024
Q4 		$635K Buy
7,129
+279
+4% +$25.1K 0.02% 444
2024
Q3 		$598K Buy
6,850
+540
+9% +$41.2K 0.02% 446
2024
Q2 		$493K Sell
6,310
-39
-0.6% -$2.6K 0.02% 471
2024
Q1 		$426K Sell
6,349
-97
-2% -$7.46K 0.02% 493
2023
Q4 		$513K Buy
6,446
+452
+8% +$35.2K 0.02% 420
2023
Q3 		$465K Buy
5,994
+376
+7% +$28.9K 0.03% 421
2023
Q2 		$425K Buy
5,618
+232
+4% +$18.5K 0.02% 455
2023
Q1 		$467K Buy
5,386
+6
+0.1% +$497 0.03% 399
2022
Q4 		$463K Buy
5,380
+177
+3% +$14K 0.03% 393
2022
Q3 		$424K Buy
5,203
+1,702
+49% +$107K 0.03% 364
2022
Q2 		$209K Buy
3,501
+218
+7% +$13.5K 0.02% 533
2022
Q1 		$208K Sell
3,283
-488
-13% -$31.2K 0.02% 510
2021
Q4 		$230K Sell
3,771
-420
-10% -$28.9K 0.02% 496
2021
Q3 		$283K Buy
4,191
+228
+6% +$16K 0.02% 455
2021
Q2 		$272K Buy
3,963
+316
+9% +$21.1K 0.02% 446
2021
Q1 		$240K Buy
3,647
+200
+6% +$12.9K 0.02% 447
2020
Q4 		$231K Sell
3,447
-518
-13% -$31.3K 0.02% 410
2020
Q3 		$233K Sell
3,965
-32
-0.8% -$2.22K 0.03% 363
2020
Q2 		$298K Buy
3,997
+1,020
+34% +$78.2K 0.04% 290
2020
Q1 		$250K Buy
+2,977
New +$206K 0.04% 285
2019
Q1 		– Sell
-4,523
Closed -$308K – 330
2018
Q4 		$308K Buy
4,523
+20
+0.4% +$1.4K 0.05% 255
2018
Q3 		$319K Sell
4,503
-100
-2% -$7.55K 0.05% 237
2018
Q2 		$326K Buy
4,603
+1,647
+56% +$116K 0.05% 220
2018
Q1 		$223K Buy
2,956
+1,950
+194% +$155K 0.04% 236
2017
Q4 		$72K Sell
1,006
-1,100
-52% -$83.5K 0.01% 404
2017
Q3 		$171K Sell
2,106
-1,206
-36% -$92.2K 0.03% 273
2017
Q2 		$236K Buy
3,312
+1,883
+132% +$125K 0.06% 175
2017
Q1 		$97K Sell
1,429
-589
-29% -$41.4K 0.03% 249
2016
Q4 		$145K Sell
2,018
-1,564
-44% -$116K 0.05% 203
2016
Q3 		$283K Sell
3,582
-269
-7% -$21.9K 0.11% 141
2016
Q2 		$321K Buy
3,851
+1,266
+49% +$112K 0.15% 95
2016
Q1 		$237K Sell
2,585
-423
-14% -$38.1K 0.12% 108
2015
Q4 		$304K Buy
3,008
+184
+7% +$19.1K 0.15% 111
2015
Q3 		$277K Buy
2,824
+9
+0.3% +$1K 0.15% 97
2015
Q2 		$330K Sell
2,815
-230
-8% -$25.1K 0.15% 99
2015
Q1 		$287K Buy
3,045
+305
+11% +$31K 0.13% 104
2014
Q4 		$258K Buy
+2,740
New +$283K 0.11% 103

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Chicago Partners Investment Group's GILD Position: Q2 2026 in Review

Chicago Partners Investment Group increased its Gilead Sciences (GILD) stake by 31% in Q2 2026, buying an estimated $311K and bringing the position to 10,079 shares worth $1.32M. The position accounts for 0.03% of the portfolio, ranked #527.

Chicago Partners Investment Group first reported a position in GILD in Q4 2014 and has held it in 43 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Chicago Partners Investment Group held 10,079 shares of Gilead Sciences worth $1.32M as of Q2 2026.
  • Chicago Partners Investment Group bought 2,357 Gilead Sciences shares in Q2 2026, an estimated $311K.
  • Gilead Sciences made up 0.03% of Chicago Partners Investment Group's portfolio in Q2 2026, its #527 holding.
  • Chicago Partners Investment Group first reported a position in Gilead Sciences in Q4 2014 and has held it in 43 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.